ARCH Venture Partners X, LLC
SEC CIK 1769012 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PRME | Prime Medicine, Inc. | 10% | 6.13M | $13.60M | — | 2 | 2022-10-24 | 2022-10-24 |
Most active insiders at PRME, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| No open-market trades in the last year. | ||||
ARCH Venture Partners X, LLC made no open-market trades at PRME in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2022-10-26 | 2022-10-24 | PRME | Prime Medicine, Inc. | ARCH Venture Partners X, LLC | 10% | P - Purchase | $17.00 | +800.0K | 6.13M | +15% | +$13.60M |
| DMI | 2022-10-26 | 2022-10-24 | PRME | Prime Medicine, Inc. | ARCH Venture Partners X, LLC | 10% | C - Cnv Deriv | — | +11.46M | 5.73M | New | — |
Purchase Sale Sale after option exercise All abbreviations